2.47
price down icon6.79%   -0.18
after-market Handel nachbörslich: 2.47
loading

Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
33.64%
4.0298
6.073 6.5382 6.2846 8.4625
Operating Income/Loss
33.64%
-4.0298
-6.073 -6.5382 -6.2846 -8.4625
Nonoperating Income/Loss
19.83%
0.0219
0.0273 0.1105 0.0299 0.0967
Income/Loss From Continuing Operations Before Tax
33.71%
-4.0079
-6.0457 -6.4276 -6.2547 -8.3658
Income Tax Expense/Benefit
64.29%
0.00284
0.00795 0.00521 0.00473 -
Income/Loss From Continuing Operations After Tax
33.75%
-4.0108
-6.0536 -6.4328 -6.2595 -8.3658
Net Income/Loss
33.75%
-4.0108
-6.0536 -6.4328 -6.2595 -8.3658
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
45.82%
72.69
49.85 48.64 1.723 33.80
Basic Earnings Per Share
50.00%
-0.06
-0.12 -0.13 -0.15 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):